{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:05:49Z","timestamp":1790870749826,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[1999,2,1]],"date-time":"1999-02-01T00:00:00Z","timestamp":917827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chest"],"published-print":{"date-parts":[[1999,2]]},"DOI":"10.1378\/chest.115.2.343","type":"journal-article","created":{"date-parts":[[2003,6,14]],"date-time":"2003-06-14T00:09:19Z","timestamp":1055549359000},"page":"343-351","source":"Crossref","is-referenced-by-count":98,"title":["Hydrofluoroalkane-134a Beclomethasone Dipropionate, 400 \u03bcg, Is as Effective as Chlorofluorocarbon Beclomethasone Dipropionate, 800 \u03bcg, for the Treatment of Moderate Asthma"],"prefix":"10.1016","volume":"115","author":[{"given":"Gary","family":"Gross","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip J.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Chervinsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Vanden Burgt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1378\/chest.115.2.343_bib1","unstructured":"Global Initiative for Asthma. Global strategy for asthma management and prevention. Bethesda, MD: National Heart, Lung, and Blood Institute, National Institutes of Health NHLBI\/WHO workshop report; 1995; National Institutes of Health publication 95-3659"},{"key":"10.1378\/chest.115.2.343_bib2","series-title":"Expert panel report 2: guidelines for the diagnosis and management of asthma. NIH publication No. 97-4051","author":"National Asthma Education and Prevention Program","year":"1997"},{"key":"10.1378\/chest.115.2.343_bib3","first-page":"683","article-title":"Optimizing inhaled drug delivery in patients with asthma","volume":"45","author":"Jackson","year":"1995","journal-title":"Br J Gen Pract"},{"key":"10.1378\/chest.115.2.343_bib4","first-page":"909","article-title":"Improving the bronchial deposition of pressurized aerosols","volume":"80","author":"Newman","year":"1981","journal-title":"Chest"},{"issue":"suppl","key":"10.1378\/chest.115.2.343_bib5","doi-asserted-by":"crossref","first-page":"S199","DOI":"10.1164\/ajrccm.157.5.rsaa-7","article-title":"Drug delivery to the small airways","volume":"157","author":"Thompson","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"issue":"suppl","key":"10.1378\/chest.115.2.343_bib6","doi-asserted-by":"crossref","first-page":"S203","DOI":"10.1164\/ajrccm.157.5.rsaa-8","article-title":"Effects of drugs on small airways","volume":"157","author":"Woolcock","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"issue":"suppl 1","key":"10.1378\/chest.115.2.343_bib7","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1089\/jam.1996.9.Suppl_1.S-77","article-title":"In vivo measurements of aerosol dose and distribution: clinical relevance","volume":"9","author":"Laube","year":"1996","journal-title":"J Aerosol Med"},{"key":"10.1378\/chest.115.2.343_bib8","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1080\/02786829408959750","article-title":"Approaches and challenges to use freon propellant replacements","volume":"22","author":"Leach","year":"1995","journal-title":"Aerosol Sci Technol"},{"key":"10.1378\/chest.115.2.343_bib9","first-page":"A667","article-title":"Improved lung deposition and decreased oropharyngeal deposition with a new CFC-free beclomethasone metered dose inhaler","volume":"155","author":"Leach","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.115.2.343_bib10","first-page":"40","article-title":"A conceptual model for the delivery of pressurized metered-dose hydrofluoroalkane-based inhalation aerosols","volume":"18","author":"June","year":"1994","journal-title":"Pharm Technol"},{"key":"10.1378\/chest.115.2.343_bib11","first-page":"91","article-title":"Improved performance characteristics of CFC-free aerosol MDIs","volume":"8","author":"June","year":"1995","journal-title":"J Aerosol Med"},{"key":"10.1378\/chest.115.2.343_bib12","series-title":"Respiratory drug delivery V proceedings","first-page":"133","article-title":"Enhanced drug delivery through reformulating MDIs with HFA propellants\u2014drug deposition and its effect on preclinical and clinical programs","author":"Leach","year":"1996"},{"issue":"suppl","key":"10.1378\/chest.115.2.343_bib13","first-page":"S131","article-title":"Efficient lung deposition of beclomethasone dipropionate via a novel multidose dry powder inhaler compared to a conventional pressurized metered dose inhaler","volume":"14","author":"Warren","year":"1997","journal-title":"Pharm Res"},{"key":"10.1378\/chest.115.2.343_bib14","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1164\/ajrccm\/136.5.1285","article-title":"Standardization of spirometry\u20141987 update: statement of the American Thoracic Society","volume":"136","year":"1987","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.115.2.343_bib15","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/BF01068419","article-title":"A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability","volume":"15","author":"Schuirmann","year":"1987","journal-title":"J Pharmacokinet Biopharm"},{"key":"10.1378\/chest.115.2.343_bib16","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1177\/009286159002400206","article-title":"Design of bioavailability\/bioequivalence studies","volume":"24","author":"Schuirmann","year":"1990","journal-title":"Drug Inf J"},{"issue":"suppl 1","key":"10.1378\/chest.115.2.343_bib17","first-page":"S42","article-title":"Safety of propellants","volume":"8","author":"Alexander","year":"1995","journal-title":"J Aerosol Med"},{"key":"10.1378\/chest.115.2.343_bib18","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0091-6749(95)70032-3","article-title":"Clinical equivalence of a novel nonchlorofluorocarbon-containing salbutamol sulfate metered-dose inhaler and a conventional chlorofluorocarbon inhaler in patients with asthma","volume":"96","author":"Dockhorn","year":"1995","journal-title":"J Allergy Clin Immunol"},{"issue":"suppl 1","key":"10.1378\/chest.115.2.343_bib19","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1089\/jam.1995.8.Suppl_1.S-41","article-title":"Clinical evaluation of CFC-free metered dose inhalers","volume":"8","author":"Jenkins","year":"1995","journal-title":"J Aerosol Med"},{"issue":"suppl A","key":"10.1378\/chest.115.2.343_bib20","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0954-6111(98)90214-1","article-title":"HFA-134a beclomethasone dipropionate extrafine aerosol provides equivalent asthma control to CFC beclomethasone dipropionate at approximately half the total daily dose","volume":"92","author":"Davie","year":"1998","journal-title":"Respir Med"},{"key":"10.1378\/chest.115.2.343_bib21","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0091-6749(93)90115-V","article-title":"Bioequivalence of metered-dose inhaled medications","volume":"92","author":"Wong","year":"1993","journal-title":"J Allergy Clin Immunol"},{"key":"10.1378\/chest.115.2.343_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003088-199426010-00001","article-title":"Standards for bioequivalence of inhaled products","volume":"26","author":"Chrystyn","year":"1994","journal-title":"Clin Pharmacokinet"},{"key":"10.1378\/chest.115.2.343_bib23","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1183\/09031936.95.08101634","article-title":"Bioequivalence of inhaled drugs","volume":"8","author":"Derom","year":"1995","journal-title":"Eur Respir J"},{"key":"10.1378\/chest.115.2.343_bib24","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/0954-6111(95)90152-3","article-title":"Assessing equivalence of inhaled drugs","volume":"89","author":"Fuller","year":"1995","journal-title":"Respir Med"},{"key":"10.1378\/chest.115.2.343_bib25","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0954-6111(95)90085-3","article-title":"Determining equivalence of inhaled medications","volume":"89","author":"Rogers","year":"1995","journal-title":"Respir Med"},{"key":"10.1378\/chest.115.2.343_bib26","first-page":"179","article-title":"Sample sizes for comparative inhaled corticosteroid trials with emphasis on showing therapeutic equivalence","volume":"48","author":"Zanen","year":"1995","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1378\/chest.115.2.343_bib27","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1136\/bmj.313.7048.36","article-title":"Trials to assess equivalence: the importance of rigorous methods","volume":"313","author":"Jones","year":"1996","journal-title":"BMJ"},{"issue":"suppl 3","key":"10.1378\/chest.115.2.343_bib28","first-page":"55","article-title":"Assessing equivalence of inhaled products","volume":"49","author":"Snell","year":"1997","journal-title":"J Pharm Pharmacol"},{"key":"10.1378\/chest.115.2.343_bib29","first-page":"321","article-title":"Personal observations on the use of inhaled corticosteroid drugs for chronic asthma","volume":"65","author":"Toogood","year":"1984","journal-title":"Eur J Respir Dis"},{"key":"10.1378\/chest.115.2.343_bib30","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1183\/09031936.97.10071640","article-title":"Glucocorticoid-resistant asthma: pathogenesis and clinical implications for management","volume":"10","author":"Szefler","year":"1997","journal-title":"Eur Respir J"},{"key":"10.1378\/chest.115.2.343_bib31","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0163-7258(93)90049-J","article-title":"Clinical pharmacology of corticosteroids in bronchial asthma","volume":"58","author":"Lipworth","year":"1993","journal-title":"Pharmacol Ther"},{"key":"10.1378\/chest.115.2.343_bib32","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1056\/NEJM199503303321307","article-title":"Inhaled glucocorticoids for asthma","volume":"332","author":"Barnes","year":"1995","journal-title":"N Engl J Med"},{"issue":"suppl 2","key":"10.1378\/chest.115.2.343_bib33","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1164\/ajrccm\/154.2_Pt_2.S58","article-title":"Steroid resistance in asthma: molecular mechanisms","volume":"154","author":"Adcock","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.115.2.343_bib34","first-page":"455","article-title":"Steroid resistance in asthma","volume":"88","author":"Barnes","year":"1995","journal-title":"Q J Med"},{"key":"10.1378\/chest.115.2.343_bib35","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1164\/ajrccm.157.3.157315","article-title":"Efficacy and safety of inhaled corticosteroids: new developments","volume":"157","author":"Barnes","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.115.2.343_bib36","series-title":"CFC-BDP requires 2.6 times the dose to achieve equivalent improvement in FEV1as HFA-BDP","author":"Busse","year":"1998"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215505746?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215505746?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,21]],"date-time":"2020-03-21T17:53:13Z","timestamp":1584813193000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369215505746"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,2]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1999,2]]}},"alternative-id":["S0012369215505746"],"URL":"https:\/\/doi.org\/10.1378\/chest.115.2.343","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[1999,2]]}}}